Provided by Tiger Trade Technology Pte. Ltd.

Progress

44.01
-0.3500-0.79%
Volume:49.16K
Turnover:2.18M
Market Cap:1.80B
PE:21.26
High:44.99
Open:44.19
Low:44.00
Close:44.36
52wk High:47.37
52wk Low:23.82
Shares:41.01M
Float Shares:40.11M
Volume Ratio:0.53
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.07
EPS(LYR):1.66
ROE:18.57%
ROA:4.89%
PB:3.57
PE(LYR):26.51

Loading ...

ClearSign Combustion Reports Q2 Progress and Board Addition

TIPRANKS
·
Aug 21

Bristol‑Myers Squibb Advances Navlimetostat Metabolism Study, Signaling Steady Pipeline Progress

TIPRANKS
·
Aug 21

Lowe's Fiscal Q2 Results Highlight Progress on Long-Term Strategy, UBS Says

MT Newswires Live
·
Aug 21

Progress Software Announces New Telerik and Kendo UI Release to Accelerate AI-Powered Development and Agent-Ready Applications

GlobeNewswire
·
Aug 20

Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company

GlobeNewswire
·
Aug 20

Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines

GlobeNewswire
·
Aug 20

Kyle Peterson Reaffirms Hold on Alight, Citing Long Sales Cycles and Gradual Financial Impact Despite Strategic Progress

TIPRANKS
·
Aug 20

YSB Inc. Reports Integration Progress and Management Commitment on Key Acquisition

TIPRANKS
·
Aug 20

JINUSHI Publishes Q2 FY2026 Briefing, Confirms Strong Progress Toward Profit Targets

TIPRANKS
·
Aug 20

The Calmer Co. to Brief Investors on FY26 Progress and Strategic Priorities

TIPRANKS
·
Aug 20

Neuronetics Earnings Call: Progress Amid Transition Risks

TIPRANKS
·
Aug 20

Eureka Details Governance Compliance and Diversity Progress for FY26

TIPRANKS
·
Aug 20

Mirrabooka Updates Market on Progress of On-Market Share Buy-Back

TIPRANKS
·
Aug 20

Arcturus Therapeutics Earnings Call Balances Progress, Pressure

TIPRANKS
·
Aug 20

Dexus Industria REIT Updates ASX on Progress of On-Market Security Buy-Back

TIPRANKS
·
Aug 20

News Corp Details Progress on US$1bn Share Repurchase Program

TIPRANKS
·
Aug 20

Challenger Updates Investors on Progress of On-Market Share Buy-Back

TIPRANKS
·
Aug 20

Abaxx Maintained at Buy as Monetization Progress and Trading Growth Offset Longer Ramp-Up, Price Target Trimmed to $60

TIPRANKS
·
Aug 20

Rockwell Medical Maintained at Buy as Operational Progress and Discounted Valuation Support Upside Despite Cut to $20 Price Target

TIPRANKS
·
Aug 20

The Bull Case For PTC Therapeutics (PTCT) Could Change Following Renal Data Progress For ST-920

Simply Wall St.
·
Aug 20